MTA2 knockdown attenuates AP1-governed MMP12 expression and inhibits the metastatic potential of cervical cancer cells attributed to ASK1/MEK3/p38-mediated YB1 phosphorylation. The gene discussed is FOS; the disease is cervical carcinoma.